Prosecution Insights
Last updated: November 20, 2026
Application No. 19/125,066

BIMETAL DIFFUSION BONDED ELECTRODE AND METHODS OF USING THE SAME

Non-Final OA §102§103
Filed
Apr 28, 2025
Priority
Oct 28, 2022 — provisional 63/420,430 +1 more
Examiner
JOHNSON, NICOLE F
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Medtronic Inc.
OA Round
1 (Non-Final)
87%
Grant Probability
Favorable
1-2
OA Rounds
1y 1m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 87% — above average
87%
Career Allowance Rate
1221 granted / 1397 resolved
+17.4% vs TC avg
Moderate +7% lift
Without
With
+7.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
38 currently pending
Career history
1450
Total Applications
across all art units

Statute-Specific Performance

§101
9.1%
-30.9% vs TC avg
§103
37.0%
-3.0% vs TC avg
§102
34.5%
-5.5% vs TC avg
§112
10.1%
-29.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1397 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-10 & 19-21 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Chen et al. (US 2014/0277316). Claim 1. Chen et al. discloses: An electrode: E.G. via the disclosed medical lead 70 having segmented electrodes, including electrode 73 ([0049]; Figs. 4A-4B). …comprising an inner metal layer: E.G. via the disclosed electrode 73 having an inner portion 78 formed of metal [0049]. More specifically, Chen discloses an electrode preform 86 comprising an inner layer 90. The inner layer has the same or similar composition as inner portion 78 ([0049] & [0055]). Chen discloses that inner portion 78, and thus corresponding inner layer 90, may comprise titanium, titanium alloys, etc. [0054]. …and an outer metal layer… E.G. via the disclosed electrode preform 86 having an outer layer 88 ([0055]; Figs. 5A-5D). Note that the outer layer 88 has the same or similar composition as outer portion 74 or electrode 73, [0059]. …the outer layer disposed at least partially around the inner metal layer…” E.G. Chen expressly describes electrode preform 86 as a “substantially tubular structure” having outer layer 88 and inner layer 90 ([0059]; Fig 5A). As shown in Fig. 5A, outer layer 88 is positioned radially outside of and extends around inner layer 90. Chen therefore discloses the outer metal layer disposed at least partially around the inner metal layer. …and diffusion bonded to the inner metal layer… E.G. Chen discloses that inner layer 90 and outer layer 88 are mechanically coupled at interface 92 and expressly identifies diffusion bonding as a technique for coupling the layers [0059]. Chen further expressly discloses that inner portion 78 and outer portion 74 may be mechanically coupled by diffusion bonding [0051]. Claim 2. Claim 2 is rejected for the reasons stated regarding claim 1. …wherein the inner metal layer comprises titanium or a titanium alloy E.G. Chen discloses inner portion 78 formed of titanium or titanium alloys, [0054]. Chen further discloses inner layer 90 having the same or similar composition as inner portion 78 [0055]. Claim 3. Claim 3 is rejected for the reasons stated regarding claim 1. …wherein the titanium alloy comprises titanium and one or more of tantalum, niobium, molybdenum, etc. E.G. Chen discloses that the titanium alloy forming inner portion 78 may include molybdenum, niobium, tantalum, etc. [0054]. Claim 4. Claim 4 is rejected for the reasons stated regarding claim 1. …wherein the inner metal layer is a titanium-15 molybdenum alloy… E.G. Chen expressly discloses that inner portion 78 may be formed of titanium alloys such as Ti-15Mo [0054]. Chen further discloses inner layer 90 having the same or similar compositions. Claim 5. Claim 5 is rejected for the reasons stated regarding claim 1. …wherein the outer layer comprises platinum or a platinum alloy… E.G. Chen discloses outer portion 74 formed of platinum or alloys of platinum [0052]. Chen further discloses outer layer 88 having the same or similar compositions as outer portion 74 [0055]. Claim 6. Claim 6 is rejected for the reasons stated regarding claim 1. …wherein the platinum alloy comprises platinum and iridum... E.G. Chen expressly identifies platinum-iridium as a preferred material for outer portion 74 and discloses that outer portion 74 may consist essentially of Pt-Ir [0052]. Chen further discloses outer layer 88 having the same or similar composition as outer portion 74 [0055]. Claim 7. Claim 7 is rejected for the reasons stated regarding claim 1. …wherein the diffusion bonding is performed at a temperature between 730°C and 750°C E.G. Chen discloses diffusion bonding titanium wire to Pt-10Ir at approx. 750°C ([0084]-[0085]). …and for a time between 175 minutes and 300 minutes… E.G. Chen discloses diffusion-bonding times of approx.. 30, 60, and 120 minutes, but does not expressly disclose a bonding time within 175-300 minutes ([0084]-[0085]). This limitation recites how the claimed electrode is manufactured and is therefor a product-by-process limitation. Chen nevertheless discloses the same diffusion-bonded electrode, and claim 7 does not recited a structural or performance characteristic distinguishing an electrode bonded for 175-300 minutes from Chen’s electrode. Accordingly, under the product-by-process analysis of MPEP §2113, Chen’s identical diffusion-bonded electrode anticipates claim 7 absent evidence that the claimed bonding time necessarily produces a structurally different product. Claim 8. Claim 8 is rejected for the reasons stated regarding claim 1. …wherein the diffusion bonding is performed at a temperature between 730°C and 738°C E.G. Chen discloses the diffusion-bonding at approx.. 750°C, rather than expressly within the claimed 730-738°C range. ([0084]-[0085]). The recited temperature is a product-by-process limitation that does not expressly define a structural difference in the resulting electrode. …and for a time between 175 minutes and 200 minutes… E.G. Chen discloses bonding durations of approx.. 30, 60, 120 minutes, rather than expressly within the claimed 175-200 minute range. ([0084]-[0085]). The recited duration is likewise a product-by-process limitation. Chen discloses the same diffusion-bonded, metal-clad electrode, and claim 8 does not recite any resulting diffusion-layer thickness, grain structure, bond strength, or other structural distinction. Therefore, under MPEP §2113, Chen’s diffusion-bonded electrode anticipates claim 8 absent evidence that the claimed processing conditions necessarily produce a structurally different electrode. Claim 9. Claim 9 is rejected for the reasons stated regarding claim 1. …wherein the diffusion bonding occurs in a high-pressure environment… E.G. Chen discloses diffusion bonding titanium and Pt-10lr at approx. 30 ksi. [0084], which constitutes a high-pressure environment. …that includes an inert gas… E.G. Chen discloses performing the diffusion bonding under 30 ksi Ar. “Ar” denotes argon, which is an inert gas [0084]. Claim 10. Claim 10 is rejected for the reasons stated regarding claim 1. …wherein the inert gas comprises Argon… E.G. [0084]. …and wherein a pressure of the high-pressure environment is about 30,000 pound -force per square inch (psi)… E.G. [0084]. Claim 19. …an implantable neural stimulator… E.G. via the disclosed implantable medical device 16 configured to provide neural stimulation, including deep-brain stimulation. ([0033]-[0036]; Fig. 1) …a lead with a proximal end connectable to the implantable neural stimulator and a distal end that includes at least one electrode… E.G. Leads 20 are connectable to implantable medical device 16 through lead extension 18 and connector block 30 and carry distal electrodes 24, 26 ([0033]-[0036]); Fig 1) …an inner metal layer… E.G. via the disclosed electrode preform 86 includes inner metal layer 90 ([0055]; Fig. 5A). …an outer metal disposed at least partially around and diffusion bonded to the inner metal layer… E.G. via the disclosed tubular outer metal layer 88 surrounds inner metal layer 90 and is diffusion bonded thereto ([0051], [0055], [0063]; Fig 5A.) Claim 20. …the inner metal layer comprises titanium or a titanium alloy… E.G. via the disclosed inner portion 78 and corresponding inner layer 90 comprises titanium or titanium alloys ([0054]-[0055]). …the outer metal layer comprises platinum or a platinum alloy… E.G. via the disclosed outer portion 74 and corresponding outer layer 88 comprise platinum or platinum alloys, including Pt-Ir ([0052], [0055], [0059]). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 11-18 & 21 is/are rejected under 35 U.S.C. 103 as being unpatentable over Chen et al. (US 2014/0277316). Claim 11. Chen discloses: …extruding an inner metal layer and an outer metal layer at least partially disposed around the inner metal layer… E.G. Chen discloses a tubular electrode preform having outer metal layer 88 disposed around inner metal layer 90 and identifies co-extrusion as a technique for forming and coupling the layers ([0050], [0059]; Fig. 5A) …diffusion bonding the inner metal layer and outer metal layer…” E.G. Chen expressly teaches diffusion bonding the inner and outer metal layers ([0051], [0055], [0063]). It would have been obvious to diffusion bond Chen’s co-extruded layers to strengthen the metallurgical interface and prevent peeling, a predictable use of Chen’s disclosed bonding techniques according to their established functions. See KSR. Claim 12. Chen renders claim 11 obvious as stated above. Chen performs diffusion bonding at approx. 750°C and demonstrates that increasing bonding duration improves bond integrity and reduces peeling ([0084]-[0085]). It would have been obvious to optimize Chen’s result-effective bonding duration, including to 175-300 minutes, to promote diffusion and improve bond strength. Chen’s 750°C falls within the claimed 730-750°C range. Claim 13. Chen renders claim 13 obvious as stated above. It would have been obvious to optimize Chen’s irrelated temperature and time parameters by slightly reducing the temperature to 730-738°C while increasing the duration to 175-200 minutes to obtain sufficient diffusion and bond integrity. Such adjustment constitutes routine optimization of known result-effective variables. Claim 14. Chen renders claim 11 obvious as stated above and further discloses the inner metal layer comprising titanium or a titanium alloy ([0054]-[0055]). See also the rejection of claim 2, incorporated herein. Claim 15. Chen renders claim 14 obvious and further discloses titanium alloys containing one or more of Mo, Nb, Ta, Zr, etc. [0054]. See also the rejection of claim 3, incorporated herein. Claim 16. Chen renders claim 11 obvious and expressly discloses inner layer 90 comprising Ti-15Mo ([0054]-[0055]). See also the rejection of claim 4, incorporated herein. Claim 17. Chen renders claim 11 obvious and expressly discloses outer layer 88 comprising platinum or a platinum alloy ([0052], [0055]). See also the rejection of claim 5, incorporated herein. Claim 18. Chen renders claim 17 obvious and expressly discloses the platinum alloy comprising platinum and iridium [0052]. See also the rejection of claim 6, incorporated herein. Claim 21. Chen discloses: …the lead comprises a Ti-15mo wire… E.G. Lead wire 80 comprises Ti-15mo ([0053], [0062]). …that connects the at least one electrode to connector rings attached to the proximal end of the lead… E.G. Chen’s lead wires electrically connect the distal electrodes to implantable device 16 and may be welded to a connector ring ([0033]-[0036], [0049], [0062]) It would have been obvious to position the connector ring at the proximal lead end to connect the distal electrode to the stimulator, a predictable placement of Chen’s connector according to its established function. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Lim et al. (US 2004/0031869) is cited as pertinent art because it discloses an electrochemical-catalyst electrode having a porous metal substrate and an compatible inner covering layer that includes titanium and titanium dioxide. The reference is not relied upon in the rejection because it does not teach or suggest the remaining limitations of the presently claimed invention. Any inquiry concerning this communication or earlier communications from the examiner should be directed to NICOLE F JOHNSON whose telephone number is (571)270-5040. The examiner can normally be reached Monday-Friday 8:00am-5:00pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at 571-270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NICOLE F JOHNSON/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Apr 28, 2025
Application Filed
Sep 10, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12796998
IDENTIFYING FOCAL SOURCES OF ARRHYTHMIA WITH MULTI ELECTRODE CATHETER
3y 11m to grant Granted Nov 17, 2026
Patent 12797094
UNIBODY RETRIEVAL BASKETS AND METHODS
3y 3m to grant Granted Nov 17, 2026
Patent 12796992
METHOD AND DEVICE FOR THE TECHNICAL SUPPORT OF THE ANALYSIS OF SIGNALS ACQUIRED BY MEASUREMENT, THE SIGNALS HAVING A TIME- AND SPACE-DEPENDENT SIGNAL CHARACTERISTIC
2y 9m to grant Granted Nov 17, 2026
Patent 12797016
Virtual Healthcare Apparatus, Methods And Systems
2y 12m to grant Granted Nov 17, 2026
Patent 12778506
BIOLOGICAL DATA MEASUREMENT SYSTEM
3y 1m to grant Granted Nov 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
87%
Grant Probability
95%
With Interview (+7.4%)
2y 8m (~1y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1397 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month